Programs | Myelosuppression: The Challenge of Managing Invasive Fungal Infections in Patients With Acute Myelogenous Leukemia

View Webcast

Satellite coordinates has changed for each broadcast, please refer to updated satellite coordinates.

Register here

Immunosuppression related to acute myelogenous leukemia (AML) and chemotherapy for treating AML places patients at risk for serious infections, including invasive fungal infections (IFIs).  The management of such opportunistic infections is a critical component in the care of patients with this type of leukemia.  Contemporary management of IFIs has become challenging due to the changing epidemiology of these infections and the difficulties related to their diagnosis.  Since monotherapy may be unsuccessful, other strategies, including combination therapy and immune enhancement strategies, have been investigated to treat IFIs.

The satellite broadcast will discuss recent changes in the epidemiology of IFIs and available methods for their identification in patients with AML.  Current and emerging approaches to the treatment of IFIs will be explored.  Additionally, the broadcast will include a debate by program faculty on important issues associated with AML-related IFIs, in a format that will encourage audience participation.  The ultimate goal of this educational program is the clinical application of program content to improve outcomes for patients being treated for AML.

• Discuss trends in the epidemiology of IFIs and methods for identifying the infections in patients with AML
• Describe morbidity expected to occur with the use of cytotoxic chemotherapeutic regimes in management of AML
• Explain treatment strategies and prophylactic options for the management of IFIs in patients with cancer
• Explain strategies to promote hematopoiesis and improve immune response in patients with cancer

Audience

This activity is intended for physicians, nurses, and other health care professionals who treat patients with leukemia.

Panel Members

Satellite Broadcast

 Accreditation Information

SCEPTER is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians.

Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is co-provided by SCEPTER^TM, Global Education Group, and Quintiles Medical Education.

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals.

The opinions expressed in this program are those of the speaker and do not necessarily reflect the opinions or recommendations of the speaker's affiliated institutions, the publisher, SCEPTER,^TM Global Education Group (the accreditor), Bayer (the commercial supporter), or CRM Healthcare.  Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients' conditions and possible contraindications or risks or without a review of any applicable manufacturer's product information and comparison with the recommendations of other authorities.